Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.

The vaccine plus a booster dose reduces the odds of preeclampsia by 30% and by as much as 58% in those with preexisting ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

Older adults of Norwegian origin and those who are unmarried face an increased risk for humerus fractures, with a higher ...

The CHMP has recommended approval of Jorveza oral suspension 0.2 mg/mL, the first licensed pediatric formulation of ...

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect ...

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade – but their use has only marginally ...

Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...

Targeting aging rather than individual diseases could add more than a decade of healthy life, researchers say, citing ...

The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a ...